Avibactam + Aztreonam
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| EMBLAVEOESEUUS | 127 mg / 42.3 mg / 500 mg | AbbVie Inc. |
| Emblaveo 1.5g/0.5g powder for concentrate for solution for infusionHKSGTW | 0.5 g/vial / 1.5 g/vial | PFIZER CORPORATION HONG KONG LIMITED |
| aztreonam and avibactamUS | 127 mg / 42.3 mg | AbbVie Inc. |
| Emblaveo 1.5g/0.5g powder for concentrate for solution for infusion vialsGB | 1,500 mg / 500 mg | Pfizer Ltd |
| Aztreonam 1.5g / Avibactam 500mg powder for solution for infusion vialsGB | 1,500 mg / 500 mg | Pfizer Ltd |
| aztreonam + avibactamES | 500 mg | Pfizer Europe Ma Eeig |
| 恩必復凍晶注射劑TW | — | 輝瑞大藥廠股份有限公司 |
| Emblaveo powder for concentrate for solution for infusion Aztreonam and Avibactam 1.5 g/0.5 g vialAU | 1,542 mg / 557 mg | Hospira Australia Pty Ltd |
| Hospira Australia Emblaveo for Injection Aztreonam and Avibactam (1.5g/0.5g) Powder for Solution for Injection Single-Dose VialAU | 1,500 mg / 500 mg | Hospira Australia Pty Ltd |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- GB · Emblaveo 1.5g/0.5g powder for concentrate for solution for infusion vials · 1 products · record
- US · EMBLAVEO · 1 products · record
- ES · EMBLAVEO · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.